Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Evaluating Liquid Biopsies for Methylomic Profiling of Prostate Cancer

ABSTRACT: Evaluating Liquid Biopsies for Methylomic Profiling of Prostate Cancer

PROVIDER: PRJNA488624 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Evaluating Liquid Biopsies for Methylomic Profiling of Prostate Cancer

Project description:Liquid biopsies offer significant potential for informing on cancer progression and therapeutic resistance via minimally invasive serial monitoring of genetic alterations. Although the cancer epigenome is a central driving force in most neoplasia, how well the tumour methylome can be monitored via liquid biopsies is relatively unknown. In this first of its kind study we made a direct comparison of two liquid biopsies: urine and blood, asking how well they represent the tumor methylome. Utilizing the Infinium Methylation EPIC BeadChip, we profiled DNA methylation in tissue, urine sediment and cell-free circulating DNA from four men with advanced stage prostate cancer. We show that both urine and plasma are viable surrogates for tumor tissue biopsies, capturing 78.63 and 62.21% of tumor-specific methylation alterations, respectively. We conclude that urine is an easily accessible and sensitive biofluid for the study of prostate cancer epigenomic alterations.

2020-04-22 | GSE119260 | GEO

Evaluating liquid biopsies for methylomic profiling of prostate cancer.

Project description: Not available

| S-EPMC7574384 | biostudies-literature

Determination of RAS Mutation Status in Liquid Biopsies in Subjects With RAS Wild-type.PERSEIDA Study

Project description:Analysis of freely circulating DNA in liquid biopsies using the BEAMing method

| 2216699 | ecrin-mdr-crc

RNA sequencing of aggressive variant prostate cancer biopsies

Project description:RNA sequencing of aggressive variant prostate cancer biopsies

| PRJNA1363876 | ENA

Practical Utility of Liquid Biopsies for Evaluating Genomic Alterations in Castration-Resistant Prostate Cancer.

Project description: Not available

| S-EPMC10216019 | biostudies-literature

4f-SAMMY-seq (Sequential Analysis of MacroMolecules Accessibility) and total RNA-seq data from prostate biopsies of 25 chemo-naïve patients (7 healthy biopsies and 18 tumor biopsies)

Project description:We used a groundbreaking epigenomic profiling technique developed in our laboratory, the 4f-SAMMY-seq, along with RNA-seq on 7 healthy biopsies and 18 prostate tumor biopsies. Our study represents the first direct examination of chromatin organization in patient-derived prostate biopsies. Leveraging differences in chromatin architecture, we identified a novel Prostate Cancer transcriptional signature associated with a favorable prognosis.

2025-08-21 | E-MTAB-14226 | biostudies-arrayexpress

Association of Multiparametric MRI Quantitative Imaging Features with Prostate Cancer Gene Expression in MRI-targeted Prostate Biopsies

Project description:Standard clinicopathological variables are inadequate for optimal management of prostate cancer patients. While genomic classifiers have improved patient risk classification, the multifocality and heterogeneity of prostate cancer can confound pre-treatment assessment. The objective is to investigate the association of multiparametric (mp)MRI quantitative features with prostate cancer risk gene expression profiles in mpMRI-guided biopsies tissues.

2016-06-07 | GSE80683 | GEO

Longitudinal analysis of personal cfDNA methylome patterns in metastatic prostate cancer [plasma]

Project description:Disease progression and therapeutic resistance are hallmarks of advanced stage prostate cancer (PCa), which remains a major cause of cancer-related mortality around the world. Longitudinal studies, coupled with the use of liquid biopsies, offer a potentially new and minimally invasive platform to study the dynamics of tumour progression. Our study aimed to investigate the dynamics of personal methylomic profiles of metastatic PCa (mPCa) patients, during disease progression and therapy administration. 52 plasma samples from 9 patients with mPCa were collected, longitudinally, over 13-21 months. After cell-free DNA (cfDNA) isolation, DNA methylation was profiled using the Infinium MethylationEPIC BeadChip and analysed using the minfi software. The top 5% most variable probes across time, within each individual, were utilised to study dynamic methylation patterns during disease progression and therapeutic response. Statistical testing was carried out to identify and validate ctDNA differentially methylated genes (DMGs). Personal cfDNA global methylation patterns were temporally stable throughout disease course. A proportion of analysed CpG sites presented a dynamic temporal pattern that was consistent with clinical events, such as therapy administration, and were prominently associated with immune response pathways. Study of ctDNA identified >2,000 DMGs with dynamic methylation patterns. We concluded that longitudinal assessment of cfDNA methylation in mPCa patients unveiled dynamic patterns associated with the occurrence of specific clinical events, thus highlighting the potential of using liquid biopsies to study PCa progression.

2021-09-01 | GSE157273 | GEO

Vibrational spectroscopy of liquid biopsies for prostate cancer diagnosis.

Project description: Not available

| S-EPMC7412923 | biostudies-literature

Transcriptome-wide gene expression analysis of prostate cancer (PCa) needle biopsies

Project description:Transcriptome-wide gene expression analysis of prostate cancer (PCa) needle biopsies

| PRJNA554132 | ENA